Glooko, a leading digital health solution provider and remote patient monitoring platform, acquired German-based firm xbird. The xbird is an AI (Artificial Intelligence) company that focuses on developing JITAI (Just In Time Adaptive Intervention) technology to support and predict patient behavior in diabetes management.
With the help of AI and machine learning technologies of xbird, the health risks of individuals can be detected easily. They detect it by analyzing behavioral and medical data and providing proper recommendations. Sensors in smartphones and wearables monitor a user’s activity and analyse the information to develop unique behavioral profiles and movements.
“We are thrilled to welcome the xbird team to the Glooko family. Our investment in xbird represents Glooko’s strategic commitment to machine learning and customized digital coaching for patients with chronic conditions,” said Russ Johannesson, Glooko’s Chief Executive Officer. “Among the many JITAI companies in the digital health landscape, xbird clearly has a superior solution, and has built successful partnerships throughout diabetes device manufacturers and clinical institutions. The combination of Glooko’s established global footprint and xbird’s exciting JITAI capabilities will allow us to improve patient outcomes.”
Sebastian Sujka, Chief Executive Officer and Co-Founder of xbird stated, “xbird and Glooko are a great fit. We share a commitment to providing solutions that address multiple chronic conditions, delivering measurable outcomes, and we have a common mission to broadly serve all patients in need. Our goal is to continue the design of digital health solutions for those living with these conditions and to make our capabilities accessible to as many patients as possible.” Mr. Sujka will join Glooko as the Managing Director of Glooko GmbH, along with all of the xbird staff.
The xbird JITAI platform will be integrated into the Glooko platform, which is widely used. The integration will help the customers get solutions regarding their health conditions.
The Incidence of Chronic Illness
A recent report shows that Germany is one of the top ten nations in the world for diabetes growth. Diabetes affects over 537 million persons globally, with 9.5 million in Germany (15.3 percent of the population). In Germany, about one in every two adults over the age of 15 has two or more chronic illnesses.
